BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Z, Miao Q, Yan F, Meng Y, Zhou P. Machine Learning in Quantitative Protein–peptide Affinity Prediction: Implications for Therapeutic Peptide Design. CDM 2019;20:170-6. [DOI: 10.2174/1389200219666181012151944] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhu J, Wei S, Huang L, Zhao Q, Zhu H, Zhang A. Molecular modeling and rational design of hydrocarbon-stapled/halogenated helical peptides targeting CETP self-binding site: Therapeutic implication for atherosclerosis. J Mol Graph Model 2020;94:107455. [PMID: 31586754 DOI: 10.1016/j.jmgm.2019.107455] [Reference Citation Analysis]
2 Chen Z, Yu X, Zhang A, Wang F, Xing Y. De Novo Hydrocarbon-Stapling Design of Single-Turn α-Helical Antimicrobial Peptides. Int J Pept Res Ther 2020;26:1711-9. [DOI: 10.1007/s10989-019-09964-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Gu Z, Yan T, Yan F. Rational design and improvement of the dimerization-disrupting peptide selectivity between ROCK-I and ROCK-II kinase isoforms in cerebrovascular diseases. J Mol Recognit 2020;33:e2835. [PMID: 31995258 DOI: 10.1002/jmr.2835] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Xiao D, Fan Z, Jiaqi W, Liu H, Shen L, He B, Zhang M. Rational molecular targeting of the inter-subunit interaction between human cardiac troponin hcTnC and hcTnI using switch peptide-competitive biogenic medicines. Comput Biol Chem 2020;87:107272. [PMID: 32438115 DOI: 10.1016/j.compbiolchem.2020.107272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhong H, He J, Yu J, Li X, Mei Y, Hao L, Wu X. Mig6 not only inhibits EGFR and HER2 but also targets HER3 and HER4 in a differential specificity: Implications for targeted esophageal cancer therapy. Biochimie 2021:S0300-9084(21)00176-0. [PMID: 34293452 DOI: 10.1016/j.biochi.2021.07.002] [Reference Citation Analysis]
6 Liu H, Xu L, Huang H, Zhao P, Yang R, Zhou Q, Liu G. Systematic profiling of clinical missence mutation effects on the intermolecular interaction between human growth hormone and its receptor in isolated growth hormone deficiency. J Mol Graph Model 2019;92:1-7. [PMID: 31279174 DOI: 10.1016/j.jmgm.2019.06.018] [Reference Citation Analysis]
7 Ji C, Zhuang J, Jiang Y, Mu J, Lin L, Chen Y. Making ERRFI1-Derived Peptides ‘Bindable’ to the Allosteric Dimerization Interface of Breast Cancer ERBB3 Kinase by Adding a Nonbonded Interaction System. Int J Pept Res Ther 2021;27:2895-904. [DOI: 10.1007/s10989-021-10298-6] [Reference Citation Analysis]
8 He X, Hao Y, Liu X, Guan J, Wang L. Noncognate HER2 sensitivity to cognate EGFR allosteric inhibitors at molecular level: New uses for old drugs in gynecological tumors. J Chinese Chemical Soc. [DOI: 10.1002/jccs.202100489] [Reference Citation Analysis]
9 Qiao Z, Wang S. Directed Molecular Engineering of Mig6 Peptide Selectivity between Proto-oncogene ErbB Family Receptor Tyrosine Kinases. Biotechnol Bioproc E 2021;26:277-85. [DOI: 10.1007/s12257-020-0102-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chen F, Wang Q, Mu Y, Sun S, Yuan X, Shang P, Ji B. Systematic profiling and identification of the peptide-mediated interactions between human Yes-associated protein and its partners in esophageal cancer. J Mol Recognit 2021;:e2947. [PMID: 34964176 DOI: 10.1002/jmr.2947] [Reference Citation Analysis]
11 Zhang W, Liu J, Zhang C, Yu X, Zhong B. Structural definition of the discrete hotspot sites of BMP-2 conformational wrist epitope and rational design of the hotspot-derived osteogenic peptides against chondrocyte senescence. Bioorg Chem 2021;116:105382. [PMID: 34598087 DOI: 10.1016/j.bioorg.2021.105382] [Reference Citation Analysis]
12 Su J, Zhou P. Machine Learning-based Modeling and Prediction of the Intrinsic Relationship between Human Emotion and Music: Intrinsic Relationship between Human Emotion and Music. ACM Trans Appl Percept . [DOI: 10.1145/3534966] [Reference Citation Analysis]
13 Yang Y, Qiu Y, Liu X, Liu Y, Yin Y, Li P. Systematic profiling of staralog response to acquired drug resistant kinase gatekeeper mutations in targeted cancer therapy. Amino Acids 2020;52:511-21. [PMID: 32206932 DOI: 10.1007/s00726-020-02832-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
14 Lu G, Li X, Zhang J, Xu Q. Molecular insight into the affinity, specificity and cross-reactivity of systematic hepatocellular carcinoma RALT interaction profile with human receptor tyrosine kinases. Amino Acids 2021;53:1715-28. [PMID: 34618235 DOI: 10.1007/s00726-021-03083-8] [Reference Citation Analysis]
15 Bo G, Cao F, Li M, Xing J, Su X, Zhu Y, Wu D. Exploring calcium ion-dependent effect on the intermolecular interaction between human secreted phospholipase A2 and its peptide inhibitors in coronary artery disease. J Mol Graph Model 2019;93:107449. [PMID: 31536875 DOI: 10.1016/j.jmgm.2019.107449] [Reference Citation Analysis]
16 Zhao G, Zhang L, Che L, Li H, Liu Y, Fang J. Revisiting bone morphogenetic protein-2 knuckle epitope and redesigning the epitope-derived peptides. J Pept Sci 2021;27:e3309. [PMID: 33619824 DOI: 10.1002/psc.3309] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhang D, He D, Pan X, Liu L. Rational Design and Intramolecular Cyclization of Hotspot Peptide Segments at YAP–TEAD4 Complex Interface. PPL 2020;27:999-1006. [DOI: 10.2174/0929866527666200414160723] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
18 Wen Q, Wang J, Guo Y. Structural Dissection and Optimization of a Cation–π–π Stacking System in Human Pregnancy-Related Serine Protease–Peptide Complex. Int J Pept Res Ther 2020;26:589-95. [DOI: 10.1007/s10989-019-09866-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Ding X, Tong C, Chen R, Wang X, Gao D, Zhu L. Systematic molecular profiling of inhibitor response to the clinical missense mutations of ErbB family kinases in human gastric cancer. Journal of Molecular Graphics and Modelling 2020;96:107526. [DOI: 10.1016/j.jmgm.2019.107526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Zhou K, Lu J, Yin X, Xu H, Li L, Ma B. Structure-based derivation and intramolecular cyclization of peptide inhibitors from PD-1/PD-L1 complex interface as immune checkpoint blockade for breast cancer immunotherapy. Biophysical Chemistry 2019;253:106213. [DOI: 10.1016/j.bpc.2019.106213] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
21 Liu Q, Zhou J, Gao J, Zhang X, Yang J, Hu C, Chu W, Yao M. Targeting the membrane fusion event of human respiratory syncytial virus with rationally designed α-helical hairpin traps. Life Sci 2021;280:119695. [PMID: 34111463 DOI: 10.1016/j.lfs.2021.119695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Shi J, Peng T, Hu J, Shao H. Human genome-wide analysis and identification of the hyperphosphorylation-elicited interactions between subarachnoid tau protein and phosphoprotein-binding domains. Biotechnol Appl Biochem 2021. [PMID: 34859923 DOI: 10.1002/bab.2297] [Reference Citation Analysis]
23 Fu Y, He P, Zhou Y, Huang S, Liang L, Liu S. Exploring the systematic effect of N ‐substituted PxxP motifs on peptoid affinity to ARHGEF5/TIM SH3 domain and its relationship with ARHGEF5/TIM activation. Proteins 2019;87:979-91. [DOI: 10.1002/prot.25760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Zhang A, Liu P, Dou C, Liu Y, Che L. Molecular conversion of MIG6 hotspot-3 peptide from the nonbinder to a moderate binder of HER2 by rational design of an orthogonal interaction system at the HER2-peptide interface. Biophys Chem 2021;276:106625. [PMID: 34077816 DOI: 10.1016/j.bpc.2021.106625] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Liu Q, Lin J, Wen L, Wang S, Zhou P, Mei L, Shang S. Systematic Modeling, Prediction, and Comparison of Domain–Peptide Affinities: Does it Work Effectively With the Peptide QSAR Methodology? Front Genet 2022;12:800857. [DOI: 10.3389/fgene.2021.800857] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
26 Zhang A, Chen Z, Yu X, Zhang L, Song Q. Rational Derivation of Osteogenic Peptides from Bone Morphogenetic Protein-2 Knuckle Epitope by Integrating In Silico Analysis and In Vitro Assay. Int J Pept Res Ther 2021;27:25-35. [DOI: 10.1007/s10989-020-10058-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Xu C, Liu X, Shen J, Sun Q, Guo X, Yang M, Leng J. Integrative identification of human serpin PAI-1 inhibitors from Dracaena dragon blood and molecular implications for inhibitor-induced PAI-1 allosterism. Biotechnol Appl Biochem 2021. [PMID: 33433923 DOI: 10.1002/bab.2100] [Reference Citation Analysis]
28 Tang W, Zhao Z, Wang C, Ye T, Yang B. Molecular design and optimization of hepatic cancer SLP76-derived PLCγ1 SH3-binding peptide with the systematic N-substitution of peptide PXXP motif. J Mol Recognit 2019;32:e2806. [PMID: 31397025 DOI: 10.1002/jmr.2806] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Yu X, Zhang A, Sun G, Li X. Molecular selectivity design of mitogen-inducible gene-derived phosphopeptides between oncogenic HER kinases. J Mol Graph Model 2020;99:107661. [PMID: 32574989 DOI: 10.1016/j.jmgm.2020.107661] [Reference Citation Analysis]
30 Fan X, Xia H, Liu X, Li B, Fang J. Computational Design and Experimental Confirmation of a Head-to-Tail Cyclic Peptide to Target Human Bone Morphogenic Protein 2 based on its Type-IA Receptor. J Bioinform Comput Biol . [DOI: 10.1142/s0219720020500213] [Reference Citation Analysis]
31 Han M, Sun D. Rational creation and systematic analysis of cervical cancer kinase–inhibitor binding profile. J Comput Aided Mol Des 2019;33:689-98. [DOI: 10.1007/s10822-019-00211-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
32 Zhang Q, Jing T, Cui X, Zhao L. Rational Molecular Profiling of Receptor-Associated Late Transducer Peptide Selectivity Across Her/Rtk Kinases. Int J Pept Res Ther 2021;27:1945-51. [DOI: 10.1007/s10989-021-10223-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
33 Wang K, Li B, Ge L, Xie Y. Molecular insight into the systematic affinity and selectivity of partner recognition sites between the WW1 and WW2 domains of human KIBRA neuroprotein. Journal of Molecular Graphics and Modelling 2022. [DOI: 10.1016/j.jmgm.2022.108258] [Reference Citation Analysis]
34 Zuo X, Zhao H, Li D. Systematic inhibitor selectivity between PARP1 and PARP2 enzymes: Molecular implications for ovarian cancer personalized therapy. J Mol Recognit 2021;34:e2891. [PMID: 33684965 DOI: 10.1002/jmr.2891] [Reference Citation Analysis]
35 Wang Q, Chen F, Liu P, Mu Y, Sun S, Yuan X, Shang P, Ji B. Scaffold-based analysis of nonpeptide oncogenic FTase inhibitors using multiple similarity matching, binding affinity scoring and enzyme inhibition assay. J Mol Graph Model 2021;105:107898. [PMID: 33784524 DOI: 10.1016/j.jmgm.2021.107898] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zhou P, Wen L, Lin J, Mei L, Liu Q, Shang S, Li J, Shu J. Integrated unsupervised-supervised modeling and prediction of protein-peptide affinities at structural level. Brief Bioinform 2022:bbac097. [PMID: 35352094 DOI: 10.1093/bib/bbac097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
37 Wu D, Luo L, Yang Z, Chen Y, Quan Y, Min Z. Targeting Human Hippo TEAD Binding Interface with YAP/TAZ-Derived, Flexibility-Reduced Peptides in Gastric Cancer. Int J Pept Res Ther 2021;27:119-28. [DOI: 10.1007/s10989-020-10069-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
38 Bao Z, Liu J, Fu J. Comprehensive binary interaction mapping of τ phosphotyrosine sites with SH2 domains in the human genome: Implications for the rational design of self-inhibitory phosphopeptides to target τ hyperphosphorylation signaling in Alzheimer's Disease. Amino Acids 2022. [PMID: 35622130 DOI: 10.1007/s00726-022-03171-3] [Reference Citation Analysis]
39 Mahmoodi-Reihani M, Abbasitabar F, Zare-Shahabadi V. In Silico Rational Design and Virtual Screening of Bioactive Peptides Based on QSAR Modeling. ACS Omega 2020;5:5951-8. [PMID: 32226875 DOI: 10.1021/acsomega.9b04302] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
40 Qi L, Gao X, Pan D, Sun Y, Cai Z, Xiong Y, Dang Y. Research progress in the screening and evaluation of umami peptides. Compr Rev Food Sci Food Saf 2022. [PMID: 35201672 DOI: 10.1111/1541-4337.12916] [Reference Citation Analysis]
41 Zhang W, Liu J, Shan H, Yin F, Zhong B, Zhang C, Yu X. Machine learning-guided evolution of BMP-2 knuckle Epitope-Derived osteogenic peptides to target BMP receptor II. Journal of Drug Targeting 2020;28:802-10. [DOI: 10.1080/1061186x.2020.1757100] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 He Y. Systematic response of staurosporine scaffold-based inhibitors to drug-resistant cancer kinase mutations. Arch Pharm (Weinheim) 2020;353:e1900320. [PMID: 32285482 DOI: 10.1002/ardp.201900320] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Li Y, Wei X, Wang Q, Li W, Yang T. Inverse screening of Simvastatin kinase targets from glioblastoma druggable kinome. Comput Biol Chem 2020;86:107243. [PMID: 32172201 DOI: 10.1016/j.compbiolchem.2020.107243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Pan C, Chen L, Zhang X, Zhang D, Song Q, Peng J, Li Q. Molecular insight into the π‐stacking interactions of human ovarian cancer PARP ‐1 with its small‐molecule inhibitors and rational design of aromatic amino acid‐rich peptides to target PARP ‐1 based on the π‐stacking network. J Chinese Chemical Soc. [DOI: 10.1002/jccs.202200004] [Reference Citation Analysis]
45 Li B, Zhang L, Wang K, Yang J. Substrate-Based Design of Human Farnesyltransferase Peptide-like Pain Antagonists. Int J Pept Res Ther 2021;27:1305-13. [DOI: 10.1007/s10989-021-10169-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Fan X, Xia H, Liu X, Li B, Fang J. Rational design of type-IA receptor-derived cyclic peptides to target human bone morphogenic protein 2. J Biosci 2019;44. [DOI: 10.1007/s12038-019-9945-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
47 Zhou W, Yang H, Wang H. Inverse in silico-in vitro fishing of unexpected paroxetine kinase targets from tumor druggable kinome. J Mol Model 2020;26:197. [PMID: 32623519 DOI: 10.1007/s00894-020-04444-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Chen H, Zhou Y, Dong Q. Structural Mapping of BMP Conformational Epitopes and Bioengineering Design of Osteogenic Peptides to Specifically Target the Epitope-Binding Sites. Cel Mol Bioeng . [DOI: 10.1007/s12195-022-00725-z] [Reference Citation Analysis]